Dr Vivek Shinde | Vice President, Clinical Development Lead, Older Adult Influenza And Rsv Vaccines
Novavax

Dr. Vivek Shinde is a research physician with training in internal medicine, preventive medicine, public health, and applied epidemiology field research from UCSF, NYU, Johns Hopkins, and the US CDC. He has over a decade of combined research and global health experience in influenza, RSV, and viral respiratory disease research, including vaccine clinical development (leading mid- and late stage vaccine development programs, including pivotal phase III efficacy vaccine trials), vaccine pharmacoepidemiology (including vaccine safety and effectiveness), and disease epidemiology.

He has held scientific and strategic leadership positions through key roles in public and private sector organizations at the local, national, and international levels, including the US CDC, the NYC Department of Health, WHO Geneva, GlaxoSmithKline Vaccines, and most recently, in his role as lead of the clinical development program for pediatric and older adult RSV Vaccines at Novavax, a Washington DC metro area vaccine biotech company.